Telix Pharmaceuticals Limited (TLX)
Telix Pharmaceuticals Limited (TLX) is a healthcare company (biotechnology) based in Australia. The share price is $8.90, down 0.22% on the day, which values the company at $3.02B. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.
Key facts
- Share price
- $8.90−0.22% today
- Market value
- $3.02B
- P/E ratio
- 89.0×last 12 months
- Funk Score
- 52/100
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Telix Pharmaceuticals Limited in more detail
TLX trades at 89.0× its last twelve months' earnings, -333.2× next year's expected earnings, 3.4× sales.
Its Funk Score is 52 out of 100 (financial strength 2.4, profitability 3.1, growth 10.0, each out of 10).
In its favour: Altman Z in the safe zone. Worth checking: Weak Piotroski score; Thin interest cover.
1 of the superinvestors tracked here hold TLX, including Andrew Spokes (0.0% of the portfolio).
Superinvestors holding TLX
1 of the investors tracked here report a position in their latest 13F filing.
- Andrew Spokes Farallon Capital Management0.02% of portfolio · $4.6M · new · Q3 2026
Telix Pharmaceuticals Limited (TLX): questions and answers
What is TLX's P/E ratio?
Telix Pharmaceuticals Limited trades at 89.0× its last twelve months' earnings and -333.2× next year's expected earnings.
What is Telix Pharmaceuticals Limited's market cap?
Telix Pharmaceuticals Limited is valued at $3.02B at a share price of $8.90.
How fast is Telix Pharmaceuticals Limited growing?
Over the last three fiscal years Telix Pharmaceuticals Limited's revenue grew 94.7% a year.
Does TLX pay a dividend?
Telix Pharmaceuticals Limited does not currently pay a regular dividend.
Which famous investors own TLX?
In their latest quarterly filings, Andrew Spokes (0.0% of the portfolio) hold TLX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Telix Pharmaceuticals Limited (TLX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/TLX
Underlying data: Yahoo Finance; company filings with the SEC.